120
Participants
Start Date
February 1, 2023
Primary Completion Date
April 1, 2024
Study Completion Date
April 1, 2024
DingKunDan(GuangYuYuan)
"The experimental group would be given DingKunDan, the subjects should take 3.5g each time, twice a day.~Subjects in the control group only needed to take COC. Both groups take medicine for 3 months consecutively as a course of treatment."
Drospirenone and Ethinylestradiol Tablets (Ⅱ)
The experimental group and the control group would be given oral Drospirenone and Ethinylestradiol Tablets (Ⅱ). According to the packaging instructions, on the first day of menstruation, according to the packaging instructions, the subjects should take the tablet, then take the rest sequential at the same time every day for 28 consecutive days, menstruation would happen after drug withdrawal (or after 7 days of drug withdrawal), and the next medication cycle begin on the first day of menstruation.
Guangdong Women and Children Health Hospital, Guangzhou
Guangdong Women and Children Hospital
OTHER